ArticleScientific reports2025
Application of causal forest double machine learning (DML) approach to assess tuberculosis preventive therapy's impact on ART adherence.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Stratified Causal Inference for Intensive Care Unit Risk Prediction: Informatics-Based Modeling of Anesthetic Drug Combinations.JMIR formative research · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adherence to antiretroviral therapy (ART) is critical for HIV treatment success, yet the impact of tuberculosis preventive therapy (TPT) remains inadequately understood. Using observational data from 4152 HIV patients in Ethiopia (2005-2024), we applied causal inference methods, including Adjusted Logistic Regression, Propensity Score Matching, and Causal Forest Double Machine Learning (DML), to estimate TPT's effect on ART adherence. The DML approach (leveraging Random Forests and orthogonalization) provided the most precise estimates after model comparison. We found TPT initiation reduced adherence probability by 3.14 percentage points on average (ATE = - 0.0314; 95% CI - 0.0373, - 0.0254; p < 0.001). While most patients experienced negligible effects, substantial heterogeneity existed: individuals with advanced WHO stage, longer ART duration, higher BMI, or older age showed better adherence responses, whereas those with higher CD4 counts, functional impairment, or cotrimoxazole prophylaxis use faced greater risks. Subgroup analyses revealed consistent effects across clinical strata but greater variability among non-TPT initiators. These findings support personalized TPT deployment, prioritizing patients with advanced disease while monitoring vulnerable subgroups and highlighting the need for adherence support. Future research should validate results in multi-site cohorts using longitudinal and psychosocial data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.